XML 136 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2021
Pay vs Performance Disclosure      
Pay vs Performance Disclosure, Table
Year
Summary
Compensation
Table Total for
Dr. Aart J. de Geus¹
($)
Compensation
Actually Paid to
Dr. Aart J. de
Geus¹˒²˒³
($)
Summary
Compensation
Table Total for
Dr. Chi-Foon Chan¹
($)
Compensation
Actually
Paid to
Dr. Chi-Foon
Chan¹˒²˒³
($)
Average
Summary
Compensation
Table Total for
Non-PEO
NEOs¹
($)		Average
Compensation
Actually Paid
to Non-PEO
NEOs¹˒²˒³
($)
Value of Initial
Fixed $100
Investment
based on:4
Net Income
($ Millions)
Revenue⁵
($ Millions)
Total Stockholder Return
($)
Peer
Group
Total Stockholder Return
($)
(a)(b)(b)(c)(c)(d)(e)(f)(g)(h)(i)
202312,681,076 34,149,432 — — 7,755,213 16,756,632 213.69 150.63 1,218 5,843 
202210,058,495 10,852,624 359,853 (23,874,312)4,531,826 4,697,917 138.33 118.75 978 5,082 
20219,974,985 34,724,593 9,976,485 34,726,093 5,752,339 17,052,055 155.79 146.93 756 4,204 
    
Named Executive Officers, Footnote Aart J. de Geus was our PEO for each year presented. Chi-Foon Chan also served as our PEO for fiscal years 2021 and 2022. In June 2022, Chi-Foon Chan departed from his role as co-Chief Executive Officer. The individuals comprising the Non-PEO NEOs for each year presented are listed below.
202120222023
Sassine GhaziSassine GhaziSassine Ghazi
Trac PhamTrac PhamTrac Pham
Joseph W. LoganJoseph W. LoganShelagh Glaser
John F. Runkel, Jr.John F. Runkel, Jr.Richard Mahoney
John F. Runkel, Jr.
    
Peer Group Issuers, Footnote The Peer Group TSR set forth in this table utilizes the S&P 500 Information Technology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our 2023 Annual Report on Form 10-K. The comparison assumes $100 was invested for the period starting October 28, 2020, through the end of the listed year in the Company and in the S&P 500 Information Technology Index, respectively. Historical stock performance is not intended to forecast nor be indicative of the future stock performance of our common stock.    
Adjustment To PEO Compensation, Footnote Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEOs and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards columns below are the totals derived from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.
Year
Summary
Compensation
Table Total for
Dr. Aart J. de Geus
($)
Exclusion of Stock
Awards and Option
Awards for
Dr. Aart J. de Geus
($)
Inclusion of Equity
Values for
Dr. Aart J. de Geus
($)
Compensation
Actually Paid to
Dr. Aart J. de Geus
($)
202312,681,076 (10,040,676)31,509,032 34,149,432 
202210,058,495 (6,917,445)7,711,574 10,852,624 
20219,974,985 (7,000,335)31,749,943 34,724,593 
Year
Summary
Compensation
Table Total for
Dr. Chi-Foon Chan
($)
Exclusion of Stock
Awards and Option
Awards for
Dr. Chi-Foon Chan
($)
Inclusion of Equity
Values for
Dr. Chi-Foon Chan
($)
Compensation
Actually Paid to
Dr. Chi-Foon Chan
($)
2022359,853 — (24,234,165)(23,874,312)
20219,976,485 (7,000,335)31,749,943 34,726,093 
Year
Average Summary
Compensation Table
Total for
Non-PEO NEOs
($)
Average Exclusion
of Stock Awards
and Option Awards
for Non-PEO NEOs
($)
Average Inclusion
of Equity Values
for Non-PEO NEOs
($)
Average
Compensation
Actually Paid to
Non-PEO NEOs
($)
20237,755,213 (6,262,064)15,263,483 16,756,632 
20224,531,826 (2,915,464)3,081,555 4,697,917 
20215,752,339 (3,550,338)14,850,054 17,052,055 
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
Year
Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day of
Year for
Dr. Aart J. de Geus
($)
Change in Fair
Value from Last
Day of Prior
Year to Last
Day of Year of
Unvested Equity
Awards for
Dr. Aart J. de Geus
($)
Vesting-Date Fair
Value of Equity
Awards Granted
During Year
that Vested
During Year for
Dr. Aart J. de Geus
($)
Change in Fair
Value from Last
Day of Prior
Year to Vesting
Date of Unvested
Equity Awards
that Vested
During Year for
Dr. Aart J. de Geus
($)
Fair Value at
Last Day of
Prior Year of
Equity Awards
Forfeited During
Year for
Dr. Aart J. de Geus
($)
Total - Inclusion
of Equity
Values for
Dr. Aart J. de Geus
($)
202317,046,538 10,716,817 — 3,745,677 — 31,509,032 
20229,012,310 (2,469,818)— 1,169,082 — 7,711,574 
202111,872,810 15,087,710 — 4,789,423 — 31,749,943 
Year
Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day
of Year for
Dr. Chi-Foon Chan
 ($)
Change in Fair
Value from Last
Day of Prior Year
to Last Day of
Year of Unvested
Equity Awards for
Dr. Chi-Foon Chan
($)
Vesting-Date
Fair Value of
Equity Awards
Granted During
Year that
Vested During
Year for
Dr. Chi-Foon Chan
($)
Change in Fair
Value from Last
Day of Prior Year
to Vesting Date
of Unvested
Equity Awards
that Vested
During Year for
Dr. Chi-Foon Chan
($)
Fair Value at
Last Day of
Prior Year of
Equity Awards
Forfeited
During Year for
Dr. Chi-Foon Chan
($)
Total - Inclusion
of Equity
Values for
Dr. Chi-Foon Chan
($)
2022— (2)— 997,459 (25,231,622)(24,234,165)
202111,872,810 15,087,710 — 4,789,423 — 31,749,943 
Year
Average
Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day of
Year for
Non-PEO NEOs
($)
Average Change
in Fair Value
from Last Day of
Prior Year to
Last Day of Year of
Unvested Equity
Awards for
Non-PEO NEOs
($)
Average
Vesting-Date
Fair Value of
Equity Awards
Granted During
Year that
Vested During
Year for
Non-PEO NEOs
($)
Average Change
in Fair Value
from Last Day of
Prior Year to
Vesting Date of
Unvested Equity
Awards that
Vested During
Year for
Non-PEO NEOs
($)
Average Fair
Value at Last
Day of Prior
Year of Equity
Awards Forfeited
During Year for
Non-PEO NEOs
($)
Total - Average
Inclusion of
Equity Values for
Non-PEO NEOs
($)
20239,942,936 4,238,538 512,879 1,614,686 (1,090,556)15,263,483 
20223,798,356 (1,211,198)— 494,397 — 3,081,555 
20216,021,489 6,843,763 — 1,984,802 — 14,850,054 
    
Non-PEO NEO Average Total Compensation Amount $ 7,755,213 $ 4,531,826 $ 5,752,339
Non-PEO NEO Average Compensation Actually Paid Amount $ 16,756,632 4,697,917 17,052,055
Adjustment to Non-PEO NEO Compensation Footnote Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEOs and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards columns below are the totals derived from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.
Year
Summary
Compensation
Table Total for
Dr. Aart J. de Geus
($)
Exclusion of Stock
Awards and Option
Awards for
Dr. Aart J. de Geus
($)
Inclusion of Equity
Values for
Dr. Aart J. de Geus
($)
Compensation
Actually Paid to
Dr. Aart J. de Geus
($)
202312,681,076 (10,040,676)31,509,032 34,149,432 
202210,058,495 (6,917,445)7,711,574 10,852,624 
20219,974,985 (7,000,335)31,749,943 34,724,593 
Year
Summary
Compensation
Table Total for
Dr. Chi-Foon Chan
($)
Exclusion of Stock
Awards and Option
Awards for
Dr. Chi-Foon Chan
($)
Inclusion of Equity
Values for
Dr. Chi-Foon Chan
($)
Compensation
Actually Paid to
Dr. Chi-Foon Chan
($)
2022359,853 — (24,234,165)(23,874,312)
20219,976,485 (7,000,335)31,749,943 34,726,093 
Year
Average Summary
Compensation Table
Total for
Non-PEO NEOs
($)
Average Exclusion
of Stock Awards
and Option Awards
for Non-PEO NEOs
($)
Average Inclusion
of Equity Values
for Non-PEO NEOs
($)
Average
Compensation
Actually Paid to
Non-PEO NEOs
($)
20237,755,213 (6,262,064)15,263,483 16,756,632 
20224,531,826 (2,915,464)3,081,555 4,697,917 
20215,752,339 (3,550,338)14,850,054 17,052,055 
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
Year
Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day of
Year for
Dr. Aart J. de Geus
($)
Change in Fair
Value from Last
Day of Prior
Year to Last
Day of Year of
Unvested Equity
Awards for
Dr. Aart J. de Geus
($)
Vesting-Date Fair
Value of Equity
Awards Granted
During Year
that Vested
During Year for
Dr. Aart J. de Geus
($)
Change in Fair
Value from Last
Day of Prior
Year to Vesting
Date of Unvested
Equity Awards
that Vested
During Year for
Dr. Aart J. de Geus
($)
Fair Value at
Last Day of
Prior Year of
Equity Awards
Forfeited During
Year for
Dr. Aart J. de Geus
($)
Total - Inclusion
of Equity
Values for
Dr. Aart J. de Geus
($)
202317,046,538 10,716,817 — 3,745,677 — 31,509,032 
20229,012,310 (2,469,818)— 1,169,082 — 7,711,574 
202111,872,810 15,087,710 — 4,789,423 — 31,749,943 
Year
Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day
of Year for
Dr. Chi-Foon Chan
 ($)
Change in Fair
Value from Last
Day of Prior Year
to Last Day of
Year of Unvested
Equity Awards for
Dr. Chi-Foon Chan
($)
Vesting-Date
Fair Value of
Equity Awards
Granted During
Year that
Vested During
Year for
Dr. Chi-Foon Chan
($)
Change in Fair
Value from Last
Day of Prior Year
to Vesting Date
of Unvested
Equity Awards
that Vested
During Year for
Dr. Chi-Foon Chan
($)
Fair Value at
Last Day of
Prior Year of
Equity Awards
Forfeited
During Year for
Dr. Chi-Foon Chan
($)
Total - Inclusion
of Equity
Values for
Dr. Chi-Foon Chan
($)
2022— (2)— 997,459 (25,231,622)(24,234,165)
202111,872,810 15,087,710 — 4,789,423 — 31,749,943 
Year
Average
Year-End Fair
Value of Equity
Awards Granted
During Year
That Remained
Unvested as of
Last Day of
Year for
Non-PEO NEOs
($)
Average Change
in Fair Value
from Last Day of
Prior Year to
Last Day of Year of
Unvested Equity
Awards for
Non-PEO NEOs
($)
Average
Vesting-Date
Fair Value of
Equity Awards
Granted During
Year that
Vested During
Year for
Non-PEO NEOs
($)
Average Change
in Fair Value
from Last Day of
Prior Year to
Vesting Date of
Unvested Equity
Awards that
Vested During
Year for
Non-PEO NEOs
($)
Average Fair
Value at Last
Day of Prior
Year of Equity
Awards Forfeited
During Year for
Non-PEO NEOs
($)
Total - Average
Inclusion of
Equity Values for
Non-PEO NEOs
($)
20239,942,936 4,238,538 512,879 1,614,686 (1,090,556)15,263,483 
20223,798,356 (1,211,198)— 494,397 — 3,081,555 
20216,021,489 6,843,763 — 1,984,802 — 14,850,054 
    
Compensation Actually Paid vs. Total Shareholder Return
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our Non-PEO NEOs, the Company’s cumulative TSR, and our Peer Group TSR, in each case, over the three most recently completed fiscal years. In June 2022, Chi-Foon Chan departed from his role as co-Chief Executive Officer, at which point his unvested awards terminated, resulting in negative ‘compensation actually paid’ for those forfeited awards.
PEO AND AVERAGE NON-PEO NEO COMPENSATION ACTUALLY PAID VERSUS COMPANY TSR AND S&P 500 INFORMATION TECHNOLOGY TSR
02_425818-1_barchart_peo-and-nonpeo_P&NP-VS-TSR.jpg
barchart_peoandaveragenonpeo-legend 01.jpg
Dr. Aart J. de Geus Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 02.jpg
Dr. Chi-Foon Chan Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 03.jpg
Average Non-PEO NEO Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 04.jpg
Synopsys, Inc. TSR
barchart_peoandaveragenonpeo-legend 05.jpg
S&P 500 Information Technology TSR
    
Compensation Actually Paid vs. Net Income
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our Non-PEO NEOs, our Net Income and our Revenue, in each case, during the three most recently completed fiscal years. In June 2022, Dr. Chi-Foon Chan departed from his role as co-Chief Executive Officer, at which point his unvested awards terminated, resulting in negative ‘compensation actually paid’ for those forfeited awards.
PEO AND AVERAGE NON-PEO NEO COMPENSATION ACTUALLY PAID VERSUS NET INCOME AND REVENUE
02_425818-1_barchart_peo-and-nonpeo_P&NP-VS-NetIncome.jpg
barchart_peoandaveragenonpeo-legend 01.jpg
Dr. Aart J. de Geus Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 02.jpg
Dr. Chi-Foon Chan Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 03.jpg
Average Non-PEO NEO Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 05.jpg
Synopsys, Inc. Net Income
barchart_peoandaveragenonpeo-legend 04.jpg
Synopsys, Inc. Revenue
    
Compensation Actually Paid vs. Company Selected Measure
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our Non-PEO NEOs, our Net Income and our Revenue, in each case, during the three most recently completed fiscal years. In June 2022, Dr. Chi-Foon Chan departed from his role as co-Chief Executive Officer, at which point his unvested awards terminated, resulting in negative ‘compensation actually paid’ for those forfeited awards.
PEO AND AVERAGE NON-PEO NEO COMPENSATION ACTUALLY PAID VERSUS NET INCOME AND REVENUE
02_425818-1_barchart_peo-and-nonpeo_P&NP-VS-NetIncome.jpg
barchart_peoandaveragenonpeo-legend 01.jpg
Dr. Aart J. de Geus Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 02.jpg
Dr. Chi-Foon Chan Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 03.jpg
Average Non-PEO NEO Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 05.jpg
Synopsys, Inc. Net Income
barchart_peoandaveragenonpeo-legend 04.jpg
Synopsys, Inc. Revenue
    
Total Shareholder Return Vs Peer Group
The following chart sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our Non-PEO NEOs, the Company’s cumulative TSR, and our Peer Group TSR, in each case, over the three most recently completed fiscal years. In June 2022, Chi-Foon Chan departed from his role as co-Chief Executive Officer, at which point his unvested awards terminated, resulting in negative ‘compensation actually paid’ for those forfeited awards.
PEO AND AVERAGE NON-PEO NEO COMPENSATION ACTUALLY PAID VERSUS COMPANY TSR AND S&P 500 INFORMATION TECHNOLOGY TSR
02_425818-1_barchart_peo-and-nonpeo_P&NP-VS-TSR.jpg
barchart_peoandaveragenonpeo-legend 01.jpg
Dr. Aart J. de Geus Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 02.jpg
Dr. Chi-Foon Chan Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 03.jpg
Average Non-PEO NEO Compensation Actually Paid
barchart_peoandaveragenonpeo-legend 04.jpg
Synopsys, Inc. TSR
barchart_peoandaveragenonpeo-legend 05.jpg
S&P 500 Information Technology TSR
    
Tabular List, Table
Revenue
Compound Annual Growth Rate of Revenue
Non-GAAP Operating Margin
Backlog(1)
rTSR(2)
    
Total Shareholder Return Amount $ 213.69 138.33 155.79
Peer Group Total Shareholder Return Amount 150.63 118.75 146.93
Net Income (Loss) $ 1,218,000,000 $ 978,000,000 $ 756,000,000
Company Selected Measure Amount 5,843,000,000 5,082,000,000 4,204,000,000
Additional 402(v) Disclosure The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.We determined Revenue, as calculated in accordance with GAAP, to be our Company-Selected Measure as we deem it to be the most important financial performance measure used to link Company performance to Compensation Actually Paid to our PEO and Non-PEO NEOs in 2023. “Backlog” means contracted but unsatisfied or partially unsatisfied performance obligations as of October 31, 2023, which includes non-cancellable Flexible Spending Account (FSA) commitments from customers where actual product selection and quantities of specific products or services are to be determined by customers at a later date, and excludes future sales-based royalty payments from the remaining performance obligations. Approximately 40% of the backlog as of October 31, 2023, excluding non-cancellable FSA, is expected to be recognized as revenue over the next 12 months. The majority of the remaining backlog is expected to be recognized in the next three years. "rTSR" measures Synopsys' stock price ranking as measured against the S&P 500 Information Technology Sector Index.    
Measure:: 1      
Pay vs Performance Disclosure      
Name Revenue    
Measure:: 2      
Pay vs Performance Disclosure      
Name Compound Annual Growth Rate of Revenue    
Measure:: 3      
Pay vs Performance Disclosure      
Name Non-GAAP Operating Margin    
Measure:: 4      
Pay vs Performance Disclosure      
Name Backlog(1)    
Measure:: 5      
Pay vs Performance Disclosure      
Name rTSR(2)    
Aart J. de Geus [Member]      
Pay vs Performance Disclosure      
PEO Total Compensation Amount $ 12,681,076 $ 10,058,495 $ 9,974,985
PEO Actually Paid Compensation Amount $ 34,149,432 $ 10,852,624 $ 34,724,593
PEO Name Aart J. de Geus Aart J. de Geus Aart J. de Geus
Chi-Foon Chan [Member]      
Pay vs Performance Disclosure      
PEO Total Compensation Amount   $ 359,853 $ 9,976,485
PEO Actually Paid Compensation Amount   $ (23,874,312) $ 34,726,093
PEO Name   Chi-Foon Chan Chi-Foon Chan
PEO | Aart J. de Geus [Member] | Exclusion Of Stock Awards And Option Awards [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount $ (10,040,676) $ (6,917,445) $ (7,000,335)
PEO | Aart J. de Geus [Member] | Inclusion Of Equity Values [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 31,509,032 7,711,574 31,749,943
PEO | Aart J. de Geus [Member] | Equity Awards Granted During The Year, Unvested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards 17,046,538 9,012,310 11,872,810
PEO | Aart J. de Geus [Member] | Equity Awards Granted In Prior Years, Unvested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards 10,716,817 (2,469,818) 15,087,710
PEO | Aart J. de Geus [Member] | Equity Awards Granted During The Year, Vested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards 0 0 0
PEO | Aart J. de Geus [Member] | Equity Awards Granted In Prior Years, Vested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards 3,745,677 1,169,082 4,789,423
PEO | Aart J. de Geus [Member] | Equity Awards Forfeited In Current Year [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards 0 0 0
PEO | Chi-Foon Chan [Member] | Exclusion Of Stock Awards And Option Awards [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   0 (7,000,335)
PEO | Chi-Foon Chan [Member] | Inclusion Of Equity Values [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount   (24,234,165) 31,749,943
PEO | Chi-Foon Chan [Member] | Equity Awards Granted During The Year, Unvested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards   0 11,872,810
PEO | Chi-Foon Chan [Member] | Equity Awards Granted In Prior Years, Unvested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards   (2) 15,087,710
PEO | Chi-Foon Chan [Member] | Equity Awards Granted During The Year, Vested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards   0 0
PEO | Chi-Foon Chan [Member] | Equity Awards Granted In Prior Years, Vested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards   997,459 4,789,423
PEO | Chi-Foon Chan [Member] | Equity Awards Forfeited In Current Year [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards   (25,231,622) 0
Non-PEO NEO | Exclusion Of Stock Awards And Option Awards [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount (6,262,064) (2,915,464) (3,550,338)
Non-PEO NEO | Inclusion Of Equity Values [Member]      
Pay vs Performance Disclosure      
Adjustment to Compensation, Amount 15,263,483 3,081,555 14,850,054
Non-PEO NEO | Equity Awards Granted During The Year, Unvested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards 9,942,936 3,798,356 6,021,489
Non-PEO NEO | Equity Awards Granted In Prior Years, Unvested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards 4,238,538 (1,211,198) 6,843,763
Non-PEO NEO | Equity Awards Granted During The Year, Vested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards 512,879 0 0
Non-PEO NEO | Equity Awards Granted In Prior Years, Vested [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards 1,614,686 494,397 1,984,802
Non-PEO NEO | Equity Awards Forfeited In Current Year [Member]      
Pay vs Performance Disclosure      
Adjustment To Compensation Amount, Equity Awards $ (1,090,556) $ 0 $ 0